PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML

This study is ongoing, but not recruiting participants.

Study NCT00303290 Information provided by M.D. Anderson Cancer Center

First Received: March 15, 2006 Last Updated: September 2, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	January 2013 (Final data collection date for primary outcome measure)